Project Abstract

Actinic keratosis (AK) is a common precancerous skin condition that is primarily caused by prolonged exposure to ultraviolet (UV) radiation from the sun. These lesions, if left untreated, have the potential to progress into invasive squamous cell carcinoma, a type of skin cancer. Effective management of AK is crucial to prevent the development of skin cancer and improve patient outcomes. In this project, we aim to investigate the efficacy of topical photodynamic therapy (PDT) as a treatment modality for the management of actinic keratosis. Photodynamic therapy is a non-invasive, targeted approach that involves the application of a photosensitizing agent, followed by the activation of this agent using a specific wavelength of light. The photochemical reaction induced by this process leads to the selective destruction of abnormal or precancerous cells, while minimizing the impact on healthy surrounding tissue. Topical PDT has emerged as a promising option for the treatment of AK, as it offers the potential to address multiple lesions simultaneously and improve patient convenience compared to other conventional therapies. The primary objective of this project is to evaluate the clinical efficacy of topical PDT in the management of actinic keratosis. The study will involve a randomized, controlled clinical trial, where participants with confirmed AK lesions will be randomly assigned to either the topical PDT treatment group or a control group receiving a standard treatment approach. Participants in the PDT group will undergo a standardized protocol involving the application of a photosensitizing agent, followed by exposure to a specific wavelength of light. The primary outcome measure will be the complete clearance of AK lesions at the end of the treatment period, as assessed by experienced dermatologists. Secondary outcome measures will include the incidence of adverse events, patient-reported outcomes, and the long-term durability of the treatment effect. The study will also explore potential predictive factors, such as the anatomical location of the lesions and patient characteristics, that may influence the response to topical PDT. The findings of this project will contribute to the existing body of knowledge on the management of actinic keratosis and provide valuable insights into the potential of topical PDT as a treatment modality. If the results demonstrate the superior efficacy of topical PDT compared to standard treatments, it could lead to the adoption of this approach as a preferred option for the management of AK, ultimately improving patient outcomes and reducing the burden of skin cancer. Furthermore, the insights gained from this project may have broader implications for the use of photodynamic therapy in the treatment of other dermatological conditions, opening up new avenues for research and clinical application. By exploring the efficacy of this innovative approach, this project aims to advance the understanding and clinical management of actinic keratosis, with the ultimate goal of improving the overall quality of life for patients affected by this condition.

Project Overview